524 related articles for article (PubMed ID: 18314616)
21. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
22. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
Gao F; Carter G; Tseng G; Chivukula M
Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
[TBL] [Abstract][Full Text] [Related]
23. Lobular neoplasia on core needle biopsy does not require excision.
Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
[TBL] [Abstract][Full Text] [Related]
25. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
[TBL] [Abstract][Full Text] [Related]
26. Loss of chromosome 16q in lobular carcinoma in situ.
Etzell JE; Devries S; Chew K; Florendo C; Molinaro A; Ljung BM; Waldman FM
Hum Pathol; 2001 Mar; 32(3):292-6. PubMed ID: 11274638
[TBL] [Abstract][Full Text] [Related]
27. Fine-needle aspiration cytology of lobular carcinoma in situ.
Ustün M; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
[TBL] [Abstract][Full Text] [Related]
28. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
29. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
[TBL] [Abstract][Full Text] [Related]
30. In situ and invasive lobular neoplasia of the breast.
Hanby AM; Hughes TA
Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
[TBL] [Abstract][Full Text] [Related]
31. Risk counseling and management in patients with lobular carcinoma in situ.
Garreau JR; Nelson J; Look R; Walts D; Mahin D; Homer L; Johnson N
Am J Surg; 2005 May; 189(5):610-4; discussion 614-5. PubMed ID: 15862506
[TBL] [Abstract][Full Text] [Related]
32. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
34. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
[TBL] [Abstract][Full Text] [Related]
35. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
Li HY; Ren GS; Arnould N; Brettes JP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
[TBL] [Abstract][Full Text] [Related]
36. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
Visscher DW; Wallis TL; Crissman JD
Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
[TBL] [Abstract][Full Text] [Related]
38. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]